Fengkui K. Zhang

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 145 publications

A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.

A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.

Journal: Molecular genetics and metabolism reports

Published: March 02, 2026

Evidence- and opinion-based consensus from Delphi round 1 of the Asian aplastic anemia recommendation development.

Evidence- and opinion-based consensus from Delphi round 1 of the Asian aplastic anemia recommendation development.

Journal: International journal of hematology

Published: January 30, 2026

The profile of clinical and laboratory features of Chinese VEXAS syndrome patients with hematological abnormalities: a single-center case series.

The profile of clinical and laboratory features of Chinese VEXAS syndrome patients with hematological abnormalities: a single-center case series.

Journal: Frontiers in immunology

Published: January 23, 2026

Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection.

Who is at risk? Clinical features and a predictive model for 30-day mortality in hematologic patients with enterococcal bloodstream infection.

Journal: Frontiers in cellular and infection microbiology

Published: December 07, 2025

A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.

A real-world, multi-center, prospective, observational study for paroxysmal nocturnal haemoglobinuria (PNH) in China: Baseline characteristics, disease burden and treatment patterns.

Journal: Therapeutic advances in hematology

Published: November 11, 2025

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy.

Cyclosporine related adverse events in aplastic anemia patients treated with immunosuppressive therapy.

Journal: Annals of hematology

Published: September 03, 2025

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients.

Clinical characteristics and efficacy of short-course antibiotic therapy for Staphylococcus aureus bacteremia in hematological patients.

Journal: Microbiology spectrum

Published: August 12, 2025

Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overload.

Longitudinal clinical and preclinical studies identify hetrombopag as a potent chelator for systemic iron overload.

Journal: HemaSphere

Published: July 30, 2025

Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China.

Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 06, 2025

Efficacy and safety of immunosuppressive therapy versus cyclosporine combined with avatrombopag in older adults with severe aplastic anemia: a multicenter prospective study.

Efficacy and safety of immunosuppressive therapy versus cyclosporine combined with avatrombopag in older adults with severe aplastic anemia: a multicenter prospective study.

Journal: Blood cancer journal

Published: May 01, 2025

Association between stress hyperglycemia ratio and mortality in critically ill patients across different glucose metabolic status and diabetes mellitus subtypes.

Association between stress hyperglycemia ratio and mortality in critically ill patients across different glucose metabolic status and diabetes mellitus subtypes.

Journal: Endokrynologia Polska

Published: April 14, 2025

A comparative analysis of clinical outcomes in hematological patients afflicted with bacteremia attributable to carbapenem-resistant Klebsiella pneumoniae versus Escherichia coli.

A comparative analysis of clinical outcomes in hematological patients afflicted with bacteremia attributable to carbapenem-resistant Klebsiella pneumoniae versus Escherichia coli.

Journal: Frontiers in cellular and infection microbiology

Published: March 26, 2025

Showing 1-12 of 145

Last Updated: 09/26/2026